Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice.

When human tumor xenotransplants into nude mice are used as experimental models, it is important to know whether their microvascular anatomy is rather host or tumor specific. Therefore a morphometric comparison of the vascular network in human squamous cell carcinomas and their xenotransplants was carried out. Biopsies were taken from surgical specimens of three squamous cell carcinomas of the oral cavity. Part of the material was processed for histology and the rest was cut into 1-mm3 cubes and transplanted s.c. into the lateral thorax of athymic nude mice [NCr/Sed(nu/nu)]. The microvascular architecture of original tumors and of three first, one second, and one late generation xenografts was compared. Capillaries were identified in original human tumors by anti-factor VIII staining and in xenografts with antilaminin staining. The median distances between interphase tumor cells and blood vessels were determined and were found to be much longer in original human tumors than in xenografts, ranging from 81 microns to 99 microns and 53 microns to 65 microns, respectively. However, the characteristic qualitative histology of tumors appeared to be preserved in xenotransplants. Analysis of the topographic distribution of mitotic figures revealed that in both original tumors and xenotransplants proliferation of tumor cells was concentrated around blood vessels. Again, vascular distances in original tumors were significantly longer than in xenotransplants. In addition, xenotransplants into nude mice from a long passaged cell line from a human pharyngeal squamous cell carcinoma, FaDu, was investigated. FaDu showed a rare-fication of the capillary network with increasing tumor volume, but a constant median distance of mitotic figures from blood vessels. In conclusion, the pattern of spatial distribution of proliferating tumor cells as well as differentiation characteristics appear to be retained in xenograft tumors, but the density of the vascular system is host specific. This has to be taken into account when physiological parameters of blood supply are studied in xenotransplanted tumors.

[1]  D. Chaplin Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT). , 1986, British Journal of Cancer.

[2]  A. Zietman,et al.  Quantitative transplantation assays of spontaneous tumors of the C3H mouse as allografts in athymic NCr/Sed-nu/nu nude mice and isografts in C3Hf/Sed mice. , 1988, Cancer research.

[3]  S. Lauk Endothelial alkaline phosphatase activity loss as an early stage in the development of radiation-induced heart disease in rats. , 1987, Radiation research.

[4]  P Vaupel,et al.  Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. , 1987, Cancer research.

[5]  N. Fusenig,et al.  Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. , 1983, Cancer research.

[6]  E. Butcher,et al.  Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies. , 1987, Journal of immunology.

[7]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[8]  H. Koch,et al.  Mikroangiographische Untersuchungen verschiedener menschlicher Tumoren nach Transplantation auf thymusaplastische Nacktmäuse , 1983 .

[9]  I. Tannock Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. , 1970, Cancer research.

[10]  E. Rofstad,et al.  Vascular structure of five human malignant melanomas grown in athymic nude mice. , 1982, British Journal of Cancer.

[11]  R. Sutherland Importance of critical metabolites and cellular interactions in the biology of microregions of tumors , 1986, Cancer.

[12]  K. Smith,et al.  Vascular markers for murine tumours. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  G. Adams,et al.  Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. , 1988, British Journal of Cancer.